US 10844090
Hemiasterlin derivatives for conjugation and therapy
granted A61KA61K38/00A61K47/6817
Quick answer
US patent 10844090 (Hemiasterlin derivatives for conjugation and therapy) held by Sutro Biopharma, Inc. expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sutro Biopharma, Inc.
- Grant date
- Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K47/6817, A61K47/6855, A61P